These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 4721804)

  • 1. [Therapeutic effects of lividomycin in the retreatment for pulmonary tuberculosis patients].
    Yamamoto M; Fukuhara T; Aoyagi T
    Kekkaku; 1973 Apr; 48(4):121-7. PubMed ID: 4721804
    [No Abstract]   [Full Text] [Related]  

  • 2. [Studies on the therapeutic effects of lividomycin in retreatment for pulmonary tuberculosis (author's transl)].
    Donomae I; Fujita S; Gomi J; Hibino S; Horai Z
    Kekkaku; 1974 Jan; 49(1):21-7. PubMed ID: 4827206
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical study on tuberactinomycin-N, a new antibiotic].
    Osato T; Toyoara M
    Kekkaku; 1972 Jun; 47(6):177-80. PubMed ID: 5081206
    [No Abstract]   [Full Text] [Related]  

  • 4. [Pyridoxine insufficiency in patients with tuberculosis during antibiotic therapy].
    Shmelev NA; Krasheninnikova MA; Klochkova GS; Vil'shanskaia FL; Kozulitsyna TI
    Klin Med (Mosk); 1974 Dec; 52(12):21-7. PubMed ID: 4444239
    [No Abstract]   [Full Text] [Related]  

  • 5. [Pulmonary tuberculosis and megamycetoma: observations on 8 cases].
    Lo Schiavo L; Scarpazza G; Fici G; Avallone R
    G Ital Mal Torace; 1969; 23(6):299-300 passim. PubMed ID: 5403799
    [No Abstract]   [Full Text] [Related]  

  • 6. [Results of treatment with ethambutol and capreomycin in chronic pulmonary tuberculosis].
    Kozakow H; Potworowska M; Janowiec M; Klimkiewicz H; Niemirowski J; Pszonicka A; Pecyna-Sielewicz J; Polazek E; Rykowska Z; Frenkel A
    Gruzlica; 1969 Jul; 37(7):659-68. PubMed ID: 5350928
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment with capreomycin, with special reference to toxic effects.
    Hesling CM
    Tubercle; 1969 Mar; 50():Suppl:39-41. PubMed ID: 5402544
    [No Abstract]   [Full Text] [Related]  

  • 8. Modern methods for assessing the drugs used in the chemotherapy of mycobacterial disease.
    Mitchison DA
    Soc Appl Bacteriol Symp Ser; 1996; 25():72S-80S. PubMed ID: 8972122
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical study on the therapy of pulmonary tuberculosis with Capreomycin].
    Saishin Igaku; 1966 Jan; 21(1):164-77. PubMed ID: 5965936
    [No Abstract]   [Full Text] [Related]  

  • 10. [Intermittent method of treatment of patients with pulmonary tuberculosis showing poor tolerance of antitubercular agents].
    Sushkin AG
    Vrach Delo; 1973 Nov; 11():94-7. PubMed ID: 4786944
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effectiveness of hyposensitization in drug intolerance in patients with pulmonary tuberculosis].
    Spesivtsev OG; Prosvetov IuV; Gal'chanskaia LD
    Probl Tuberk; 1987; (12):30-3. PubMed ID: 3444822
    [No Abstract]   [Full Text] [Related]  

  • 12. [Use of dipromonium in the comprehensive treatment of patients with pulmonary tuberculosis].
    Markova EF; Avetisian RI; Avanesian NA; Beglarian NR
    Probl Tuberk; 1988; (10):67-8. PubMed ID: 3231613
    [No Abstract]   [Full Text] [Related]  

  • 13. [Prevention of residual changes in patients with pulmonary tuberculosis by pathogenetic therapy].
    Iakovlev NI
    Probl Tuberk; 1977 Dec; (12):46-50. PubMed ID: 609549
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical study of tuberactinomycin-N in pulmonary tuberculosis (author's transl)].
    Donomae I; Fujita S; Gomi J; Hibino S; Horai Z
    Kekkaku; 1973 Oct; 48(10):473-9. PubMed ID: 4780239
    [No Abstract]   [Full Text] [Related]  

  • 15. The early bactericidal activity of streptomycin.
    Donald PR; Sirgel FA; Venter A; Smit E; Parkin DP; Van de Wal BW; Doré CJ; Mitchison DA
    Int J Tuberc Lung Dis; 2002 Aug; 6(8):693-8. PubMed ID: 12150481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effectiveness of prolonged antibacterial therapy in newly detected patients with active pulmonary tuberculosis].
    Kuropatkin IF; Chuprova KP
    Probl Tuberk; 1967; 45(9):32-5. PubMed ID: 5606475
    [No Abstract]   [Full Text] [Related]  

  • 17. [Relapses in pulmonary tuberculosis. Value of the case history for the selection of the best retreatment regimen].
    Pilheu JA; de Salvo MC; Gnecco V; Giannattasio J; Hoffman M
    Medicina (B Aires); 1982; 42(4):389-95. PubMed ID: 15171020
    [No Abstract]   [Full Text] [Related]  

  • 18. [Methods of therapy of patients with chronic destructive pulmonary tuberculosis].
    Utkin VV; Rudoĭ NM
    Klin Med (Mosk); 1968 Dec; 46(12):36-43. PubMed ID: 5737381
    [No Abstract]   [Full Text] [Related]  

  • 19. [Characteristics of the reactions of patients with fibrous-cavernous pulmonary tuberculosis to anti-bacterial preparations].
    Butenko GE; Noreĭko BV
    Vrach Delo; 1971 Aug; 8():80-2. PubMed ID: 5143073
    [No Abstract]   [Full Text] [Related]  

  • 20. [Easy handling of tirizidone in the therapy of pulmonary tuberculosis in sanatoria].
    Ricci S; Zuccali G
    G Ital Mal Torace; 1970; 24(2):85-6 passim. PubMed ID: 5495224
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.